Romeo A. Mandanas - Concepedia

Concepedia

Author

Romeo A. Mandanas

Indiana University – Purdue University Indianapolis

Also Known As

R A Mandanas, R Mandanas, R. Mandanas, R.A. Mandanas, ROMEO A. MANDANAS, Romeo A Mandanas, Romeo A. Mandanas, Romeo Ang Mandanas, Romeo Mandanas

32

Publications

1.2K

Citations

11

H-Index

28

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Integris Health University of Oklahoma Health Sciences Center Indiana University School of Medicine

RA

About

Romeo A. Mandanas is an author at Indiana University – Purdue University Indianapolis specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	699
2	Health Sciences	3	3	107
3	Blood Transplantation	2	2	30
4	Cellular Therapies	2	2	30
5	Gastroenterology	1	1	34

Romeo A. Mandanas

×

13

Publications

1.2K

Citations

11

H-Index

	Year	Citations
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial Cathy Eng, Tae Won Kim, Johanna C. Bendell, The Lancet Oncology Cobimetinib Versus RegorafenibOncologyMedicinePathologyColorectal Cancer	2019	543
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J. Beyer, A. Kramar, Romeo A. Mandanas, Journal of Clinical Oncology	1996	319
Health‐related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care David J. Kuter, Susan D. Mathias, Mathias Rummel, American Journal of Hematology Quality Of LifeImmunologyPharmacotherapyImmunotherapyThrombosis	2012	77
Topical Transforming Growth Factor-β3 in the Prevention or Alleviation of Chemotherapy-Induced Oral Mucositis in Patients with Lymphomas or Solid Tumors María Cecilia Foncuberta, P. J. Cagnoni, Christian Brandts, Journal of Immunotherapy	2001	52
Bullous esophagitis due to chronic graft-versus-host disease. A Minocha, Romeo A. Mandanas, M Kida, PubMed Chronic GvhdTransplantationBullous EsophagitisEsophagusImmunology	1997	34
Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors. E. Randolph Broun, C R Nichols, Romeo A. Mandanas, PubMed	1995	31
Pegfilgrastim Appears Equivalent to Daily Dosing of Filgrastim to Treat Neutropenia After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Non-Hodgkin Lymphoma Robert M. Rifkin, Gary Spitzer, Gregory Orloff, Clinical Lymphoma Myeloma & Leukemia Lymphoid NeoplasiaCell TherapyTransplantationPegfilgrastim Appears EquivalentStem Cell Transplantation	2010	20
Phase II Trial of Cimetidine in Metastatic Melanoma Romeo A. Mandanas, Daniel C. Scullin, Lawrence H. Einhorn American Journal of Clinical Oncology	1991	17
Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: Examination of a preemptive plan of ganciclovir therapy Romeo A. Mandanas, Ruben A. Saez, George B. Selby, American Journal of Hematology	1996	17
Randomized Phase II Study of Cetuximab and Bevacizumab in Combination with Two Regimens of Paclitaxel and Carboplatin in Chemonaive Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer Philip Bonomi, Joseph R. Mace, Romeo A. Mandanas, Journal of Thoracic Oncology Chemonaive PatientsMedicineMetronomic TherapyPathologyPhase Ii Study	2013	15

Page 1